Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database

Abstract

Background The usefulness of right heart catherization (RHC) has long been debated, and thus, we aimed to study the real‐world impact of the use of RHC in cardiogenic shock. Methods and Results In the Nationwide Readmissions Database using International Classification of Diseases, Tenth Revision ( ICD‐1 0 ), we identified 236 156 patient hospitalizations with cardiogenic shock between 2016 and 2017. We sought to evaluate the impact of RHC during index hospitalization on management strategies, complications, and outcomes as well as on 30‐day readmission rate. A total 25 840 patients (9.6%) received RHC on index admission. The RHC group had significantly more comorbidities compared with the non‐RHC group. During the index admission, the RHC group had lower death (25.8% versus 39.5%, P <0.001) and stroke rates (3.1% versus 3.4%, P <0.001). Thirty‐day readmission rates (18.7% versus 19.7%, P =0.04) and death on readmission (7.9% versus 9.3%, P =0.03) were also lower in the RHC group. After adjustment, RHC was associated with lower index admission mortality (odds ratio, 0.69; 95% CI, 0.66–0.72), lower stroke rate (odds ratio, 0.81; 95% CI, 0.72–0.90), lower 30‐day readmission (odds ratio, 0.83; 95% CI, 0.78–0.88), and higher left ventricular assist device implantations/orthotopic heart transplants (odds ratio, 6.05; 95% CI, 4.43–8.28) during rehospitalization. Results were not meaningfully different after excluding patients with cardiac arrest. Conclusions RHC use in cardiogenic shock is associated with improved outcomes and increased use of downstream advanced heart failure therapies. Further blinded randomized studies are required to confirm our findings.

An artificial intelligence-based noninvasive solution to estimate pulmonary artery pressure

“…when PA pressures are obtained (22). In addition, Ranka et al presented a validated real-world analysis, although not randomized (23).…”

Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies

“…Invasive assessment with a Swan-Ganz (or similar) catheter represents a valuable tool in patients with undefined haemodynamics. 44 , 45 Arrhythmias, including atrial fibrillation, are commonly found in severe CRS. 27 , 34 Treatment should be according to current guidelines, including optimization of serum electrolytes, antiarrhythmic therapy (e.g.…”

Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices

“…Although historical studies such as ESCAPE (Evaluation Study of Congestive heart failure And Pulmonary artery catheterization Effectiveness) suggested limited utility and possible harm with the use of PAC, many, including ESCAPE, actively excluded patients with CS [ 18 ]. More recently, observational studies of large cohorts have revealed that PAC in CS is associated with more aggressive therapy [ 19 , 20 ] and improved survival [ 20 , 21 ]. PAC as a diagnostic tool can lend greater precision to hemodynamic profiling and contribute to expediting decision-making and rapid stabilization, all of which contribute to improved clinical outcomes.…”

“…Congestion, a central factor contributing to poor outcomes in HF-CS, may persist despite adequate circulatory support with MCS and vasoactive therapies [ 12 , 20 ]. Acute kidney injury (AKI) in this setting is not uncommon, and is associated with poor outcomes [ 3 ].…”